the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
28.6 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

KLIA shooting suspect arrived at Kota Bharu court for remand extension

PETALING JAYA: The suspect involved in the Kuala Lumpur International Airport 1 (KLIA 1) shooting has arrived at the Kota Bharu court this morning for his remand order extension.

38-year-old Hafizul Harawi arrived in court at 8.35am today escorted by policemen, the New Straits Times reported.

The suspect’s seven day remand order issued on the day of his arrest on Monday (April 15), expires today.

Selangor police chief Comm Datuk Hussein Omar Khan said that police would look into extending Hafizul’s remand order for another week on Sunday (April 21).

It was also revealed that the suspect was making preparations for a new job offer in Saudi Arabia.

ALSO READ: KLIA shooting – Suspect was preparing for new job in Saudi Arabia: Police

Hussein added that Hafizul was believed to have gone to Kelantan to collect his medical records after doing a check-up a week prior to the shooting incident.

Besides that, Hussein added that police have managed to record statements from 27 individuals including the suspect.

The gun Hafizul used to target his wife was reportedly purchased at RM5,000 from a Thai national.

Hafizul was arrested on Monday (April 15) in Kota Bharu after attempting to flee from the scene where he intended to shoot his wife but hit a bodyguard, Muhammad Nur Hadith, 38, at his abdominal area on Sunday (April 14).

The bodyguard had undergone surgery on April 16 but was reported to have remained unconscious but in stable condition after the procedure was done at Hospital Cyberjaya.

ALSO READ: “I still love my wife” – KLIA shooter

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings